Natixis Grows Position in Colgate-Palmolive (NYSE:CL)

Natixis grew its position in Colgate-Palmolive (NYSE:CL - Free Report) by 25.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 190,167 shares of the company's stock after acquiring an additional 38,829 shares during the quarter. Natixis' holdings in Colgate-Palmolive were worth $17,288,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in CL. Chicago Partners Investment Group LLC boosted its stake in shares of Colgate-Palmolive by 16.2% during the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company's stock valued at $591,000 after purchasing an additional 943 shares during the period. Aviva PLC lifted its holdings in Colgate-Palmolive by 13.4% during the 4th quarter. Aviva PLC now owns 973,421 shares of the company's stock valued at $88,494,000 after buying an additional 114,855 shares in the last quarter. Peak Financial Advisors LLC purchased a new stake in Colgate-Palmolive in the 4th quarter valued at about $1,315,000. Fiduciary Alliance LLC bought a new position in Colgate-Palmolive in the 4th quarter worth about $4,066,000. Finally, Impact Partnership Wealth LLC purchased a new position in shares of Colgate-Palmolive during the fourth quarter worth approximately $803,000. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock traded down $1.23 on Thursday, hitting $92.66. The company's stock had a trading volume of 11,290,917 shares, compared to its average volume of 4,646,598. The company has a market capitalization of $75.16 billion, a price-to-earnings ratio of 26.32, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The firm has a fifty day moving average price of $91.78 and a 200-day moving average price of $92.31. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the business posted $0.87 earnings per share. As a group, sell-side analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive announced that its board has initiated a stock buyback program on Thursday, March 20th that permits the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization permits the company to repurchase up to 6.8% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's management believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Thursday, April 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.24%. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's payout ratio is currently 59.09%.

Wall Street Analysts Forecast Growth

CL has been the topic of several research reports. Piper Sandler reduced their price objective on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a report on Monday, March 31st. UBS Group raised their price target on Colgate-Palmolive from $105.00 to $109.00 and gave the company a "buy" rating in a research note on Thursday, April 17th. Raymond James reaffirmed an "outperform" rating and issued a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. JPMorgan Chase & Co. dropped their target price on shares of Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a report on Friday, April 11th. Finally, Morgan Stanley reduced their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating for the company in a report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $102.17.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.